Filana Therapeutics, Inc. (FLNA) — Tangible Net Worth Ratio
Filana Therapeutics, Inc. (FLNA) has a Tangible Net Worth Ratio of 100.0% as of June 2026. This metric is calculated by deducting intangible assets ($0.00) from net assets ($63.61 Million) and expressing it as a percentage of total net assets. A higher ratio means that more of the company's equity is backed by tangible, balance-sheet-verifiable assets rather than goodwill, patents, or brand value. Also explore net asset momentum of Filana Therapeutics, Inc. to track the company's year-over-year net asset growth rate.
Tangible NW Ratio
Net Assets (Equity)
Intangible Assets
Total Assets
Filana Therapeutics, Inc. Tangible Net Worth Ratio (2022–2025)
This chart shows how Filana Therapeutics, Inc.'s Tangible Net Worth Ratio has changed across 4 annual periods from 2022 to 2025. As of June 2026, the ratio stands at 100.0%, reflecting net assets of $63.61 Million with intangible assets of $0.00 USD. For live market cap and overall valuation, see FLNA market cap overview.
Annual Tangible Net Worth Ratio for Filana Therapeutics, Inc. (2022–2025)
The table below presents the year-by-year Tangible Net Worth Ratio for Filana Therapeutics, Inc. from 2022 to 2025, covering 4 annual filings. Each row shows net assets, intangible assets, total assets, the tangible net worth ratio, and the change in percentage points versus the prior year. See FLNA FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Tangible NW Ratio | Net Assets (USD) | Intangible Assets | Total Assets | Change (pp) |
|---|---|---|---|---|---|
| 2025 | 100.0% | $74.40 Million | $0.00 | $118.36 Million | ▲ +0.0 pp |
| 2024 | 100.0% | $145.70 Million | $37.00K | $157.53 Million | ▲ +0.1 pp |
| 2023 | 99.9% | $137.47 Million | $176.00K | $151.66 Million | ▲ +0.1 pp |
| 2022 | 99.7% | $227.54 Million | $622.00K | $234.83 Million | — |